Testing effectiveness (Phase 2)Study completedNCT02948569
What this trial is testing
Evaluation of 3-V Bioscience-2640 to Reduce de Novo Lipogenesis in Subjects With Characteristics of Metabolic Syndrome
Who this might be right for
Metabolic Syndrome
University of Missouri-Columbia 12